Video

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Written byThermo Fisher Scientific
| 1 min read
GreenCooling

Thermo Fisher Scientific

Thermo Scientific™ Centrifuges with GreenCool Technology are Greener by Design and bring outstanding power and enhanced sustainability to the laboratory. Equipped with a next-generation cooling system, these centrifuges exemplify technological leadership and innovation. The advanced cooling system complies with the F-Gas Regulation (EU) 2024/573 and US EPA regulations, which aim to reduce the emission of fluorinated greenhouse gases to mitigate their impact on climate change. Fluorinated gases, including hydrofluorocarbons (HFCs), perfluorocarbons (PFCs), and sulfur hexafluoride (SF6), have a high global warming potential (GWP). These regulations seek to limit the use, production, and release of these gases.

Thermo Scientific GreenCool Technology for floor-standing centrifuges operates with carbon dioxide (CO2), a natural gas with a Global Warming Potential of 1, lower than other refrigerants. Additionally, CO2 does not deplete the ozone layer.

Beyond the F-Gas compliant technology, the centrifuges offer reduced energy consumption and excellent temperature stability, helping ensure the integrity of samples as well as precise and efficient results. Their lighter weight and reduced noise levels further enhance the laboratory environment, making it more conducive for scientists. By leveraging application-specific solutions, these models unleash the full potential of a greener technology for top performance with every spin. Speak to a specialist for more information.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue